These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26005373)

  • 1. Major pathophysiological correlations of rosacea: a complete clinical appraisal.
    Vemuri RC; Gundamaraju R; Sekaran SD; Manikam R
    Int J Med Sci; 2015; 12(5):387-96. PubMed ID: 26005373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiology of rosacea.
    Mc Aleer MA; Lacey N; Powell FC
    G Ital Dermatol Venereol; 2009 Dec; 144(6):663-71. PubMed ID: 19907405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosacea and the pilosebaceous follicle.
    Powell FC
    Cutis; 2004 Sep; 74(3 Suppl):9-12, 32-4. PubMed ID: 15499752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options.
    Steinhoff M; Schmelz M; Schauber J
    Acta Derm Venereol; 2016 Jun; 96(5):579-86. PubMed ID: 26714888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cutaneous rosacea: emphasis on new medical therapies.
    Del Rosso JQ
    Expert Opin Pharmacother; 2014 Oct; 15(14):2029-38. PubMed ID: 25186025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin.
    Del Rosso JQ; Gallo RL; Kircik L; Thiboutot D; Baldwin HE; Cohen D
    J Drugs Dermatol; 2012 Jun; 11(6):694-700. PubMed ID: 22648215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of rosacea with topical ivermectin.
    Ali ST; Alinia H; Feldman SR
    Drugs Today (Barc); 2015 Apr; 51(4):243-50. PubMed ID: 26020066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of altered cutaneous immune responses in the induction and persistence of rosacea.
    Margalit A; Kowalczyk MJ; Żaba R; Kavanagh K
    J Dermatol Sci; 2016 Apr; 82(1):3-8. PubMed ID: 26747056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demodex and rosacea revisited.
    Moran EM; Foley R; Powell FC
    Clin Dermatol; 2017; 35(2):195-200. PubMed ID: 28274359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosacea: a review of current topical, systemic and light-based therapies.
    Kennedy Carney C; Cantrell W; Elewski BE
    G Ital Dermatol Venereol; 2009 Dec; 144(6):673-88. PubMed ID: 19907406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species and rosacea.
    Jones D
    Cutis; 2004 Sep; 74(3 Suppl):17-20, 32-4. PubMed ID: 15499754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging therapies in rosacea.
    Layton A; Thiboutot D
    J Am Acad Dermatol; 2013 Dec; 69(6 Suppl 1):S57-65. PubMed ID: 24229638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosacea as an inflammatory disorder: a unifying theory?
    Millikan LE
    Cutis; 2004 Jan; 73(1 Suppl):5-8. PubMed ID: 14959939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosacea: I. Etiology, pathogenesis, and subtype classification.
    Crawford GH; Pelle MT; James WD
    J Am Acad Dermatol; 2004 Sep; 51(3):327-41; quiz 342-4. PubMed ID: 15337973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosacea: an update on medical therapies.
    Chang BP; Kurian A; Barankin B
    Skin Therapy Lett; 2014; 19(3):1-4. PubMed ID: 25188361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demodicosis: a clinicopathological study.
    Hsu CK; Hsu MM; Lee JY
    J Am Acad Dermatol; 2009 Mar; 60(3):453-62. PubMed ID: 19231642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of rosacea.
    Cohen AF; Tiemstra JD
    J Am Board Fam Pract; 2002; 15(3):214-7. PubMed ID: 12038728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rigor of trials evaluating Rosacea treatments.
    van Zuuren EJ; Graber MA
    Cutis; 2005 Mar; 75(3 Suppl):13-6; discussion 33-6. PubMed ID: 15810805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proposed inflammatory pathophysiology of rosacea: implications for treatment.
    Millikan L
    Skinmed; 2003; 2(1):43-7. PubMed ID: 14673323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional evidence that rosacea pathogenesis may involve demodex: new information from the topical efficacy of ivermectin and praziquantel.
    Abokwidir M; Fleischer AB
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.